Skip to content

Central Pathology Lab Operations

State-of-the-art central lab powering clinical trials with AI digital pathology

Artificial intelligence will transform the next generation of precision medicine clinical trials

Unlock PathAI's cutting-edge biomarker and scoring algorithms for endpoint analysis and patient enrollment with our central pathology lab that seamlessly integrates AI into clinical trial workflows. Our specialties include NASH, IBD and Oncology.

Introduction to PathAI's Biopharma Lab Services

+ Watch Video

Introduction to PathAI's Biopharma Lab Services

+ Watch Video

Introduction to PathAI's Biopharma Lab Services

+ Watch Video

End-to-End Pathology Operations & Services

Patients-people-team-2

Pathology Read Strategy

Clinical Development

Site Training

Slide-Prep-15 (1)

Receipt, Processing & Staining

Scanning & Digitization

Viewer-Software-Machine3-3

Manual Central Pathology Reads

Image Analysis

AI-powered Reads

report-study-2

Reporting

Query Resolution

Data Transfer

Establishing the highest level of trust with our partners

  • 8 successful audits by biopharma and CROs
  • ZERO critical findings in audits to date
  • 550+ board-certified pathologists available for central reads
  • 2:1 low trial manager-to-trial ratio for high touch service and secure data delivery
  • 12 active or upcoming trials across >8 biopharma partners
iStock-1263308819-1400px

Our focus and deep expertise matters when trial success critically depends on pathology strategy and operations

Reduce-Re-Work-13

Unmatched operational excellence

Our focus and deep expertise in pathology maximizes quality and compliance without compromising turn-around time

Check-List-13 (1)

Comprehensive and fit-for-purpose

Full end-to-end anatomical and digital pathology operations, from block receipt through slide digitization, with multiple staining equipment & scanners for flexible protocols

Network-13

White-glove partnership

Dedicated clinical trial and data managers to shape the optimal pathology read strategy, ensure robust site training, organize operations across multiple sites and partners, and rapidly resolve challenges

Our Central Pathology Lab Services

E2E-lab-services-image

AISight Clinical Trials

We power clinical trials with our compliant AISightTM digital pathology platform for algorithm deployment and image analysis, specially designed for clinical trial workflows.

Learn More
AISight-lab-monitor-scaled
Grossing

Contact Us

Connect with our team to learn more about PathAI's state-of-the-art central lab and how it's powering clinical trials with AI

Contact Us

1AISight® and PathAI Algorithms (including AIM-PD-L1, AIM-HER2, AIM-ER, AIM-PR, AIM-Ki-67, AIM-MASH+, MET Dysregulation NSCLC, AIM-HI, and PathAssist Derm are For Research Use Only in the United States. Not for use in diagnostic procedures. AISight® Dx is FDA-cleared for primary diagnosis in the US and is CE‑IVD–marked for primary diagnosis in the EEA, UK, and Switzerland.

2ArtifactDetect, TumorDetect, and AIM-TumorCellularity are workflow tools accessed via the AISight Image Management digital pathology platform. AISight® is for Research Use Only in the United States. AISight® Dx is FDA-cleared for primary diagnosis in the US with the Hamamatsu NanoZoomer® S360MD and Leica Aperio® GT 450 DX slide scanners, and is CE‑IVD–marked for primary diagnosis in the EEA, UK, and Switzerland.